Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicare | 10 | 2024 | 612 | 1.960 |
Why?
|
| Neoplasms | 7 | 2023 | 1371 | 1.840 |
Why?
|
| Blogging | 3 | 2022 | 10 | 1.790 |
Why?
|
| Patient Satisfaction | 7 | 2022 | 436 | 1.580 |
Why?
|
| Medicaid | 2 | 2019 | 361 | 0.920 |
Why?
|
| Health Equity | 1 | 2023 | 46 | 0.770 |
Why?
|
| Social Determinants of Health | 2 | 2023 | 137 | 0.740 |
Why?
|
| Emergency Service, Hospital | 3 | 2021 | 1105 | 0.720 |
Why?
|
| Video Games | 1 | 2021 | 13 | 0.690 |
Why?
|
| United States | 17 | 2024 | 7837 | 0.670 |
Why?
|
| Medicare Part C | 1 | 2020 | 14 | 0.670 |
Why?
|
| Quality of Health Care | 3 | 2021 | 519 | 0.640 |
Why?
|
| Periodicals as Topic | 2 | 2019 | 174 | 0.610 |
Why?
|
| Peer Review, Research | 1 | 2019 | 47 | 0.590 |
Why?
|
| Cancer Survivors | 4 | 2024 | 120 | 0.570 |
Why?
|
| Health Care Reform | 1 | 2019 | 87 | 0.560 |
Why?
|
| Publishing | 1 | 2019 | 92 | 0.560 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 179 | 0.560 |
Why?
|
| Life Change Events | 1 | 2018 | 66 | 0.540 |
Why?
|
| Insurance, Health | 1 | 2019 | 151 | 0.540 |
Why?
|
| Poverty Areas | 1 | 2017 | 15 | 0.520 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 301 | 0.520 |
Why?
|
| Home Care Services | 1 | 2018 | 98 | 0.520 |
Why?
|
| Mobile Applications | 1 | 2018 | 137 | 0.500 |
Why?
|
| Patient-Centered Care | 2 | 2018 | 254 | 0.500 |
Why?
|
| Primary Health Care | 2 | 2019 | 697 | 0.480 |
Why?
|
| Holistic Health | 1 | 2015 | 11 | 0.470 |
Why?
|
| Residence Characteristics | 1 | 2017 | 219 | 0.470 |
Why?
|
| Humans | 30 | 2024 | 63518 | 0.460 |
Why?
|
| Information Dissemination | 1 | 2015 | 116 | 0.410 |
Why?
|
| Aged | 14 | 2024 | 14454 | 0.410 |
Why?
|
| Telemedicine | 1 | 2018 | 330 | 0.410 |
Why?
|
| Cost of Illness | 4 | 2022 | 162 | 0.410 |
Why?
|
| Bayes Theorem | 2 | 2022 | 123 | 0.360 |
Why?
|
| Colorectal Neoplasms | 4 | 2017 | 277 | 0.290 |
Why?
|
| Home Care Agencies | 2 | 2018 | 5 | 0.270 |
Why?
|
| Opioid-Related Disorders | 2 | 2023 | 509 | 0.250 |
Why?
|
| Continuity of Patient Care | 2 | 2017 | 174 | 0.230 |
Why?
|
| Physician-Patient Relations | 3 | 2017 | 422 | 0.220 |
Why?
|
| Massachusetts | 3 | 2023 | 2074 | 0.220 |
Why?
|
| Harm Reduction | 1 | 2023 | 33 | 0.200 |
Why?
|
| Research | 1 | 2023 | 195 | 0.190 |
Why?
|
| Health Care Costs | 3 | 2023 | 215 | 0.180 |
Why?
|
| Drug Overdose | 1 | 2023 | 131 | 0.180 |
Why?
|
| Surveys and Questionnaires | 4 | 2024 | 2704 | 0.180 |
Why?
|
| Patient Care | 1 | 2022 | 79 | 0.180 |
Why?
|
| New Zealand | 1 | 2021 | 43 | 0.170 |
Why?
|
| Semantic Web | 1 | 2020 | 1 | 0.170 |
Why?
|
| Female | 10 | 2021 | 32939 | 0.170 |
Why?
|
| Fee-for-Service Plans | 1 | 2020 | 68 | 0.160 |
Why?
|
| Self Report | 2 | 2019 | 381 | 0.160 |
Why?
|
| Registries | 3 | 2019 | 873 | 0.160 |
Why?
|
| Risk Adjustment | 1 | 2020 | 94 | 0.150 |
Why?
|
| Mental Health | 1 | 2022 | 371 | 0.150 |
Why?
|
| Health Care Surveys | 1 | 2020 | 285 | 0.150 |
Why?
|
| Insurance Claim Review | 1 | 2019 | 76 | 0.150 |
Why?
|
| Male | 9 | 2020 | 29928 | 0.140 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 686 | 0.130 |
Why?
|
| Quality Improvement | 1 | 2021 | 443 | 0.130 |
Why?
|
| Focus Groups | 1 | 2018 | 305 | 0.120 |
Why?
|
| Managed Care Programs | 1 | 2017 | 89 | 0.120 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2017 | 156 | 0.120 |
Why?
|
| Health Information Exchange | 1 | 2015 | 4 | 0.110 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 5467 | 0.110 |
Why?
|
| Organizational Objectives | 1 | 2015 | 58 | 0.110 |
Why?
|
| Terminology as Topic | 1 | 2015 | 140 | 0.110 |
Why?
|
| Long-Term Care | 1 | 2015 | 177 | 0.110 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 333 | 0.110 |
Why?
|
| Communication | 1 | 2018 | 580 | 0.100 |
Why?
|
| Qualitative Research | 1 | 2018 | 705 | 0.100 |
Why?
|
| Infant | 1 | 2017 | 1654 | 0.090 |
Why?
|
| Child, Preschool | 1 | 2017 | 1999 | 0.090 |
Why?
|
| Adult | 2 | 2019 | 16891 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 604 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2019 | 6620 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2011 | 180 | 0.080 |
Why?
|
| Health Policy | 1 | 2011 | 192 | 0.080 |
Why?
|
| Health Services | 1 | 2009 | 82 | 0.080 |
Why?
|
| Carcinoma | 1 | 2009 | 124 | 0.070 |
Why?
|
| Smoking Prevention | 1 | 2009 | 162 | 0.070 |
Why?
|
| SEER Program | 2 | 2017 | 74 | 0.070 |
Why?
|
| Child | 1 | 2017 | 4541 | 0.070 |
Why?
|
| Risk Factors | 1 | 2017 | 5284 | 0.060 |
Why?
|
| Young Adult | 1 | 2017 | 4712 | 0.060 |
Why?
|
| Adolescent | 1 | 2017 | 6258 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2007 | 167 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2007 | 259 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 2584 | 0.050 |
Why?
|
| Smoking Cessation | 1 | 2009 | 548 | 0.050 |
Why?
|
| Naloxone | 1 | 2023 | 61 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2023 | 262 | 0.050 |
Why?
|
| Health Expenditures | 1 | 2023 | 122 | 0.050 |
Why?
|
| Middle Aged | 2 | 2017 | 17654 | 0.040 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2020 | 35 | 0.040 |
Why?
|
| Patient Outcome Assessment | 1 | 2020 | 54 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2009 | 2572 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 536 | 0.040 |
Why?
|
| Personnel Management | 1 | 2017 | 11 | 0.030 |
Why?
|
| Age Distribution | 1 | 2017 | 258 | 0.030 |
Why?
|
| Home Health Aides | 1 | 2017 | 30 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2017 | 99 | 0.030 |
Why?
|
| Colonoscopy | 1 | 2017 | 100 | 0.030 |
Why?
|
| Quality of Life | 1 | 2024 | 1241 | 0.030 |
Why?
|
| Nurses | 1 | 2017 | 109 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 931 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 1267 | 0.030 |
Why?
|
| State Medicine | 1 | 2011 | 12 | 0.020 |
Why?
|
| Time Factors | 2 | 2009 | 3706 | 0.020 |
Why?
|
| United Kingdom | 1 | 2011 | 80 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2011 | 64 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2011 | 102 | 0.020 |
Why?
|
| Reimbursement Mechanisms | 1 | 2009 | 40 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 243 | 0.020 |
Why?
|
| Hospice Care | 1 | 2009 | 68 | 0.020 |
Why?
|
| Forecasting | 1 | 2009 | 233 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2009 | 99 | 0.020 |
Why?
|
| Risk | 1 | 2009 | 378 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2011 | 751 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2009 | 312 | 0.020 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2007 | 13 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2007 | 64 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 1553 | 0.020 |
Why?
|
| Smoking | 1 | 2009 | 863 | 0.010 |
Why?
|
| Pregnancy | 1 | 2009 | 2335 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 662 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2009 | 844 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2009 | 5630 | 0.010 |
Why?
|